Pulmonx Corp
Pulmonx Corp (LUNG) Option Chain
As of September 18, 2026, Pulmonx Corp is trading at $2.07, a +4.55% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 126.2%. IV Rank is 19%.
Read more
Tracking the LUNG option chain helps you see every strike and expiry on Pulmonx Corp in one view, so you can quickly identify the contracts that fit your thesis and your risk. Pulmonx Corp's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of LUNG options activity at a glance. Use our scanner to monitor the LUNG option chain in real time and filter for the LUNG options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For LUNG stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the LUNG option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where LUNG stock options are being actively traded and where they are not.
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves.
It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Pulmonx Corp's full chain across every expiry, highlights the most liquid strikes, and lets you screen LUNG options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of LUNG stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile30.16% Subdued
- Market cap (M$)89
- 52 weeks high-28.37%
- 52 weeks low83.19%
- Analyst recommendationBuy
1.80 - Target price$3.40
64.25% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-1.16
- EPS growth next 5 years16.56%
As of September 18, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 81.58 | 1,720 | 36 | 0.15 | 0.00 | — | 0.15 | 2.50 | +26.26 | 0.25 | 0.95 | 0.43 | 0.17 | 0 | 0 | 18.42 |
| 99.92 | 0 | 0 | 0.05 | 0.00 | — | 0.05 | 5.00 | +152.53 | 2.50 | 3.50 | 2.93 | 0.07 | 0 | 0 | 0.08 |
| 100.00 | 0 | 0 | 0.75 | 0.00 | — | 0.75 | 7.50 | +278.79 | 5.00 | 6.00 | 5.43 | 0.07 | 0 | 0 | 0.00 |
As of September 18, 2026
Scan the full option chain in one place
Browse the full LUNG option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→